Advertisement
Progressive International Holding Company has been a strong presence inthe Asian healthcare market during the past twenty years. In view of China asone of the fastest growing countries in the world and with the rising demandfor healthcare products inland, Progressive International Holding Company hasintroduced Oxyview(R) to the Taiwan, China, Japan and Korea medical market.Not only does Progressive International Holding Company want to pursue aleading role in the diagnostic, medical device and POC markets in China, butalso has a strong position in Taiwan. With a stronghold of Primus Medical(Shanghai) and Taiwan's experience, Progressive International Holding Companyshall have a strong and unique position in the Asian healthcare market to sellOxyview(R).
Advertisement
"Ingen Technologies is working close with Progressive InternationalHolding Company to complete the registration process for Oxyview(R). Thisprocess is similar to the FDA and DHS compliances that Ingen and Oxyview(R)have already successfully completed last year," said Scott Sand, Chairman andCEO.
About Ingen Technologies, Inc.
Ingen Technologies is a new medical device manufacturer that ownsproprietary intellectual property for the growing respiratory market. TheOxyview(R) was recently assigned Class-I with the Food & Drug Administration.The Company has several other related products being scheduled for releaseduring 2008 and will continue to roll-out additional medical products duringthe next several years. The principals and management of Ingen Technologiesare committed to the success of the company and have invested more than$5 million of their own money towards R&D and the manufacturing of proprietarybiotech products for the medical market. The Company owns multiple Patents andTrademarks in the United States, European Communities, Japan, and the PeoplesRepublic of China. The Company has had revenues since 2002 with their SecureBalance(R) products, and has recently released their new Oxyview(R) productworldwide through two of the world's largest home health care distributors inthe United States, Asia and 80 other countries. Further, new markets in Asiahave been recently secured with monthly deliveries of 10,000 Oxyview(R) units.The Company's respiratory product line will benefit from the $4 billionrespiratory market that will grow to $6 billion by 2010. With 8-9% ofAmericans over 65 that have a respiratory illness and require home oxygentherapy, the world market is 10-12% and offers a growing revenue stream forthe company. The elderly population in the United States will double between2010 and 2015, increasing the number of respiratory illnesses and increasingthe need for Oxyview(R) and OxyAlert(R).
Safe Harbor for Forward-Looking Statements: This news release includesforward-looking statements. While these statements are made to convey to thepublic the company's progress, business opportunities and growth prospects,readers are cautioned that such forward-looking statements representmanagement's opinion. Whereas management believes such representations to betrue and accurate based on information and data available to the company atthis time, actual results may differ materially from those described. Thecompany's operations and business prospects are always subject to risk anduncertainties. Important factors that may cause actual results to differ areand will be set forth in the company's periodic filings with the U.S.
